T. Rowe (NASDAQ: TROW) director gets dividend reinvestment share grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PRICE T ROWE GROUP INC director Robert F. MacLellan acquired 206.3598 shares of Common Stock as a fully vested grant under the company’s 2017 Non-Employee Director Equity Plan, tied to dividends on the stock. The shares were credited as dividend reinvestment, bringing his direct holdings to 52,965.8316 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
MacLellan Robert F.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 206.36 | $89.03 | $18K |
Holdings After Transaction:
Common Stock — 52,965.832 shares (Direct)
Footnotes (1)
- [object Object]
Key Figures
Shares granted: 206.3598 shares
Reported price per share: $89.03 per share
Holdings after transaction: 52,965.8316 shares
+1 more
4 metrics
Shares granted
206.3598 shares
Dividend reinvestment grant under 2017 Non-Employee Director Equity Plan
Reported price per share
$89.03 per share
Value used for the Common Stock grant
Holdings after transaction
52,965.8316 shares
Director’s direct Common Stock holdings following grant
Acquire transactions
1 transaction
Non-derivative grant/award acquisition reported in this Form 4
Key Terms
2017 Non-Employee Director Equity Plan, dividend reinvestment shares, Common Stock
3 terms
2017 Non-Employee Director Equity Plan financial
"This is pursuant to the T. Rowe Price Group, Inc. 2017 Non-Employee Director Equity Plan with respect to dividends declared"
Common Stock financial
"with respect to dividends declared by the issuer on it's Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did TROW director Robert F. MacLellan report on this Form 4?
Robert F. MacLellan reported acquiring 206.3598 shares of PRICE T ROWE GROUP INC Common Stock. The shares were granted as fully vested dividend reinvestment shares under the company’s 2017 Non-Employee Director Equity Plan, rather than through an open-market purchase.
Was the TROW Form 4 transaction a market buy or a compensation grant?
The Form 4 for PRICE T ROWE GROUP INC shows a grant/award acquisition, not an open-market buy. MacLellan’s 206.3598 shares were credited as dividend reinvestment shares under the 2017 Non-Employee Director Equity Plan, reflecting compensation-linked reinvested dividends.
What is the T. Rowe Price 2017 Non-Employee Director Equity Plan mentioned in MacLellan’s filing?
The 2017 Non-Employee Director Equity Plan is an equity compensation program for PRICE T ROWE GROUP INC’s non-employee directors. Under this plan, dividends on Common Stock can be credited as fully vested dividend reinvestment shares, as occurred in MacLellan’s reported transaction.